Ion channel assay methods

Details for Australian Patent Application No. 2004269322 (hide)

Owner Vertex Pharmaceuticals, Inc.

Inventors Gonzalez, III Jesus E.; Maher, Michael P.

Agent Pizzeys

Pub. Number AU-B-2004269322

PCT Pub. Number WO2005/022113

Priority 10/620,312 14.07.03 US

Filing date 8 July 2004

Wipo publication date 10 March 2005

Acceptance publication date 2 September 2010

International Classifications

G01N 33/487 (2006.01) Investigating or analysing materials by specific methods not covered by groups - of liquid biological material

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/022113 Priority application(s): WO2005/022113

2 September 2010 Application Accepted

  Published as AU-B-2004269322

6 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269323-CHRNA2 genetic markers associated with galantamine response

2004269320-Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using